4-(5-氨基-2-(吡啶-3-基)噻唑并[5,4-d]嘧啶-7-基)-Np-甲苯基哌嗪-1-甲酰胺

4-(5-amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-p-tolylpiperazine-1-carboxamide (订货以英文为准)

编号:P126505
CAS号:1245319-54-3
分子式:C22H22N8OS
分子量:446.53
货号 品牌 包装 目录价 您的价格 库存 数量 购买
P126505-5mg 阿拉丁 5mg ¥2737.90
P126505-10mg 阿拉丁 10mg ¥4379.90
产品名称 4-(5-amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-p-tolylpiperazine-1-carboxamide
中文名称 4-(5-氨基-2-(吡啶-3-基)噻唑并[5,4-d]嘧啶-7-基)-Np-甲苯基哌嗪-1-甲酰胺
CAS号 1245319-54-3
分子式(M.F.) C22H22N8OS
分子量(M.W.) 446.53
储存条件 -20°C储存
溶解性25°C: DMSO
存贮条件储存温度-20°C
生化机理Description:IC50 Value: 5.7 nM[1]  PI4KIII beta inhibitor 3, 4-(5-amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-p-tolylpiperazine-1-carboxamide, is a novel and high effective PI4KIII beta inhibitor.in vitro:  The most effective test compound, the compound of formula 3 (PI4KIII beta inhibitor 3), inhibited IL2 and IFNy secretion with IC50 values of less than 1 nM in each case. Thus, the compound of formula (3) was shown to be as effective at inhibiting IL2 and IFNy secretion as conventional immunosuppressants such as cyclosporine A. IC50 on IFNy and IL-2 release of Cyclosporine A are 2nM and less than 1 nM respectively [1].in vivo: Twelve animals received daily treatment with vehicle (1%methylcellulose), twelve others received PI4KIII beta inhibitor 3 at 40 mg/kg/d in 1% methylcellulose [1].Clinical trial: N/A
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:252917-06-9
¥ 113.90 C125082-5mg
CAS号:252935-94-7
¥ 817.90 C129718-5mg
CAS号:252917-06-9
¥ 502.90 C129710-5mg
CAS号:1217486-61-7
¥ 124.90 B127311-1mg
CAS号:371935-74-9
¥ 707.90 P125961-10mg
CAS号:1173900-33-8
¥ 768.90 A129523-5mg
CAS号:900185-02-6
¥ 283.90 P129553-1mg
CAS号:915019-65-7
¥ 308.90 B126286-25mg